Clinical trial Recruiting at 1 site Observational Ages 18 to 55 Women only

Assessing mycotoxins in mothers' milk in Israel

Official title: Maternal and Newborn Exposure to Mycotoxins in Israel and the Association to Baby's Development in First Months of Life

Run by Assaf-Harofeh Medical Center · NCT05371106 · Data updated 2026-11-12

This study looks at whether harmful toxins from mold are found in the breast milk of mothers in Israel to understand any health risks for breastfeeding babies.

More Breastfeeding trials

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexWomen only
Enrollment150 (estimated)
SponsorAssaf-Harofeh Medical Center
Government
Locations1 site (Tsrifin)
StatusRecruiting
StartedSeptember 1, 2020
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedDecember 24, 2025
Trial IDNCT05371106 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include women aged 18 and above who are either pregnant after week 37 or currently breastfeeding.

Probably not a fit

Patients who are taking medications that affect milk production or are contraindicated during breastfeeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the presence of harmful mycotoxins in the breast milk of women in Israel. It focuses on identifying toxins produced by certain fungi that may contaminate food and subsequently enter the human body. The study will analyze various mycotoxins, including Aflatoxins and Fumonisins, to determine their levels in mothers' milk and investigate potential sources of contamination. By understanding the prevalence of these toxins, the study seeks to highlight health risks associated with breastfeeding in contaminated environments.

Why it matters

Potential benefit: If successful, this study could lead to improved safety guidelines for breastfeeding mothers regarding food consumption and toxin exposure.

How similar studies have gone: While studies on mycotoxins exist, this specific focus on mothers' milk in Israel is relatively novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18 and above.
* Pregnant women after week 37 intending to breastfeed.
* Women breastfeeding.

Exclusion Criteria:

* Women taking drugs which influence milk production.
* Women taking drugs contraindicated during breastfeeding.
* Women not staying in Israel during third trimester or in the months after birth for a long period of time.
* Women not wanting/able to fill up the questionnaires.

Where it's running

  • Assaf Harofeh Medical Center
    Tsrifin, Israel
    Recruiting

Study contacts

  • Principal investigator: Elkana Kohn, Ph.D. — Shamir (Assaf Harofeh) Medical Center
  • Study coordinator: Elkana Kohn, Ph.D.
  • Email: elkanak@shamir.gov.il
  • Phone: 972-8-9772181

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.